Eliza Kwapień
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Eliza Kwapień has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Jakub Bartkowski
Medicine, Miejskie Zakłady Opieki Zdrowotnej w Żorach, Żory, POL
4 shared publications - Julia Żerdka
Student Scientific Club, Department of Cardiology, Faculty of Health Sciences in Katowice, Medical University of Silesia, 40-055 Katowice, Poland
4 shared publications - Mateusz Piszka
General Practice, Wojewódzki Szpital Specjalistyczny nr 5 im. św. Barbary w Sosnowcu, Sosnowiec, POL
4 shared publications - Patryk Brasse
Student Scientific Club, Department of Cardiology, Faculty of Health Sciences in Katowice, Medical University of Silesia, 40-055 Katowice, Poland
4 shared publications - Aleksandra Owczarska
Provincial Specialist Hospital No. 5 named after St. Barbara in Sosnowiec
3 shared publications - Hubert Dacyl
Medical University of Silesia in Katowice, Poland
3 shared publications
Latest Publications
- Open Access
- 3 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 49
Teprotumumab as a Breakthrough in Thyroid Eye Disease Therapy: A Comprehensive Review
Background. Thyroid Eye Disease (TED) is a complex autoimmune condition associated with Graves' disease, causing disfigurement, visual impairment, and reduced quality of life. For decades, options were limited to non-specific anti-inflammatory treatments like glucocorticosteroids and radiotherapy, often failing to address symptoms like proptosis and diplopia. Identifying the insulin-like growth factor-1 receptor (IGF-1R) as a driver of TED pathophysiology led to targeted therapies.Aim. This study reviews teprotumumab as a breakthrough TED therapy, analyzing its mechanism, efficacy, and place in treatment algorithms relative to traditional methods.Material and methodsA literature review was conducted using databases (PubMed, Embase, ClinicalTrials.gov) for articles up to November 2025. Analysis prioritized pivotal trials (OPTIC, OPTIC-X), meta-analyses, and reviews focusing on TED pathophysiology and IGF-1R inhibition.Results. TED pathogenesis involves crosstalk between TSHR and IGF-1R on orbital fibroblasts, triggering inflammation and adipogenesis. While traditional treatments offer limited relief with side effects, teprotumumab, the first FDA-approved IGF-1R inhibitor, targets these mechanisms. Clinical data shows superior efficacy in reducing proptosis and improving diplopia compared to palliative care.Conclusions. Teprotumumab is a breakthrough in TED management, shifting from symptomatic to targeted disease modification. By addressing orbital remodeling causes, it offers distinct advantages over traditional therapies, fulfilling a major unmet need.
- 3 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 49
Open AccessTeprotumumab as a Breakthrough in Thyroid Eye Disease Therapy: A Comprehensive Review
Background. Thyroid Eye Disease (TED) is a complex autoimmune condition associated with Graves' disease, causing disfigurement, visual impairment, and reduced quality of life. For decades, options were limited to non-specific anti-inflammatory treatments like glucocorticosteroids and radiotherapy, often failing to address symptoms like proptosis and diplopia. Identifying the insulin-like growth factor-1 receptor (IGF-1R) as a driver of TED pathophysiology led to targeted therapies.Aim. This study reviews teprotumumab as a breakthrough TED therapy, analyzing its mechanism, efficacy, and place in treatment algorithms relative to traditional methods.Material and methodsA literature review was conducted using databases (PubMed, Embase, ClinicalTrials.gov) for articles up to November 2025. Analysis prioritized pivotal trials (OPTIC, OPTIC-X), meta-analyses, and reviews focusing on TED pathophysiology and IGF-1R inhibition.Results. TED pathogenesis involves crosstalk between TSHR and IGF-1R on orbital fibroblasts, triggering inflammation and adipogenesis. While traditional treatments offer limited relief with side effects, teprotumumab, the first FDA-approved IGF-1R inhibitor, targets these mechanisms. Clinical data shows superior efficacy in reducing proptosis and improving diplopia compared to palliative care.Conclusions. Teprotumumab is a breakthrough in TED management, shifting from symptomatic to targeted disease modification. By addressing orbital remodeling causes, it offers distinct advantages over traditional therapies, fulfilling a major unmet need.
- Open Access
- 13 December 2025
- Published by Springer Nature in Cureus
- Vol. 17 (12)
Habitual Coffee Consumption and Systemic Health Outcomes: A Comprehensive Review
This review analyzes extensive scientific data linking habitual coffee consumption to a wide range of physiological outcomes and divides them into cardiovascular, metabolic, and organ-specific effects. Unlike previous assumptions, moderate coffee intake positively affects many aspects of the health of the adult population. We can observe beneficial effects that translate into patients' longevity as well as reduced risks of chronic diseases. After analyzing the studies, the most significant protective associations were identified in the cardiovascular system, where moderate consumption (three to four cups daily, corresponding to approximately 450-600 mL of coffee) correlates with reduced all-cause and cardiovascular mortality, and a lower risk of heart failure. Many studies have highlighted the chemo-preventive potential of coffee constituents, indicating a reduced risk of specific malignancies, including liver and prostate cancer. The health consequences that manifest themselves clinically also include improved metabolic homeostasis, specifically a lower incidence of type 2 diabetes mellitus and liver fibrosis. This impact also extends to the central nervous system, where there is a clear correlation between caffeine intake and neuroprotection against neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease. Evidence indicates a "J-shaped" relationship in many cases, suggesting that moderate intake is optimal. Conversely, supraphysiological consumption can induce transient hemodynamic disturbances, and unfiltered preparations may negatively impact lipid profiles due to higher diterpene content. Furthermore, evidence supports a linear dose-response relationship between caffeine intake and adverse pregnancy outcomes, specifically pregnancy loss, highlighting the need for strict caution in prenatal care. Due to the proven bioactive properties of compounds like chlorogenic acid and caffeine, updated public health perspectives are needed to recognize coffee not merely as a stimulant, but as a functional dietary component that promotes a healthy lifestyle, which will translate into the reduced burden of non-communicable diseases in the future.
- 13 December 2025
- Published by Springer Nature in Cureus
- Vol. 17 (12)
Open AccessHabitual Coffee Consumption and Systemic Health Outcomes: A Comprehensive Review
This review analyzes extensive scientific data linking habitual coffee consumption to a wide range of physiological outcomes and divides them into cardiovascular, metabolic, and organ-specific effects. Unlike previous assumptions, moderate coffee intake positively affects many aspects of the health of the adult population. We can observe beneficial effects that translate into patients' longevity as well as reduced risks of chronic diseases. After analyzing the studies, the most significant protective associations were identified in the cardiovascular system, where moderate consumption (three to four cups daily, corresponding to approximately 450-600 mL of coffee) correlates with reduced all-cause and cardiovascular mortality, and a lower risk of heart failure. Many studies have highlighted the chemo-preventive potential of coffee constituents, indicating a reduced risk of specific malignancies, including liver and prostate cancer. The health consequences that manifest themselves clinically also include improved metabolic homeostasis, specifically a lower incidence of type 2 diabetes mellitus and liver fibrosis. This impact also extends to the central nervous system, where there is a clear correlation between caffeine intake and neuroprotection against neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease. Evidence indicates a "J-shaped" relationship in many cases, suggesting that moderate intake is optimal. Conversely, supraphysiological consumption can induce transient hemodynamic disturbances, and unfiltered preparations may negatively impact lipid profiles due to higher diterpene content. Furthermore, evidence supports a linear dose-response relationship between caffeine intake and adverse pregnancy outcomes, specifically pregnancy loss, highlighting the need for strict caution in prenatal care. Due to the proven bioactive properties of compounds like chlorogenic acid and caffeine, updated public health perspectives are needed to recognize coffee not merely as a stimulant, but as a functional dietary component that promotes a healthy lifestyle, which will translate into the reduced burden of non-communicable diseases in the future.
- Open Access
- 7 December 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 48
The impact of sleep duration and quality on the health of the pediatric population: consequences for mental health, eating disorders, and other diseases
Background Sleep is a fundamental biological process, the duration and quality of which are of key importance for the proper development and health of the pediatric population. Understanding the complex relationship between sleep and the pathogenesis of diseases during childhood is essential for developing effective preventive and interventional strategies aimed at supporting the holistic health of the youngest patients. Aim This review aims to provide an analysis of available scientific evidence regarding the impact of insufficient sleep duration and poor sleep quality on a wide range of health indicators in children and adolescents. Special emphasis is placed on the consequences for mental health and eating disorders. Materials and methods This review synthesizes current evidence by examining literature available on PubMed, Google Scholar, and academic sources using keywords related to the sleep duration, sleep quality, pediatric population, mental health and eating disorders. Experimental, cohort, systematic reviews and clinical studies were evaluated. Results We highlight sex- and age-dependent vulnerabilities and discuss the multifactorial interplay between sleep behavior, lifestyle factors, and disease risk.Specifically, interventions aimed at improving sleep hygiene, reducing screen exposure before bedtime, and addressing sleep disorders such as obstructive sleep apnea show promise in mitigating risks associated with obesity, hypertension, emotional disorders, and chronic inflammation. Conclusion Sleep duration and sleep quality contributes to pediatric obesity, insulin resistance, cardiometabolic risk, mental health, inflammatory processes and headache disorders. Limitations in current research, including methodological heterogeneity and reliance on subjective sleep measures, underscore the need for prospective studies. We recommend future research focus on mechanistic pathways linking sleep disturbances to specific health outcomes.
- 7 December 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 48
Open AccessThe impact of sleep duration and quality on the health of the pediatric population: consequences for mental health, eating disorders, and other diseases
Background Sleep is a fundamental biological process, the duration and quality of which are of key importance for the proper development and health of the pediatric population. Understanding the complex relationship between sleep and the pathogenesis of diseases during childhood is essential for developing effective preventive and interventional strategies aimed at supporting the holistic health of the youngest patients. Aim This review aims to provide an analysis of available scientific evidence regarding the impact of insufficient sleep duration and poor sleep quality on a wide range of health indicators in children and adolescents. Special emphasis is placed on the consequences for mental health and eating disorders. Materials and methods This review synthesizes current evidence by examining literature available on PubMed, Google Scholar, and academic sources using keywords related to the sleep duration, sleep quality, pediatric population, mental health and eating disorders. Experimental, cohort, systematic reviews and clinical studies were evaluated. Results We highlight sex- and age-dependent vulnerabilities and discuss the multifactorial interplay between sleep behavior, lifestyle factors, and disease risk.Specifically, interventions aimed at improving sleep hygiene, reducing screen exposure before bedtime, and addressing sleep disorders such as obstructive sleep apnea show promise in mitigating risks associated with obesity, hypertension, emotional disorders, and chronic inflammation. Conclusion Sleep duration and sleep quality contributes to pediatric obesity, insulin resistance, cardiometabolic risk, mental health, inflammatory processes and headache disorders. Limitations in current research, including methodological heterogeneity and reliance on subjective sleep measures, underscore the need for prospective studies. We recommend future research focus on mechanistic pathways linking sleep disturbances to specific health outcomes.
- Open Access
- 29 November 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 47, 66794
The influence of the microbiome on the development and course of bronchial asthma – a comprehensive review
Background Asthma is a chronic airway disease increasingly linked to alterations in the human microbiome. Early-life disruptions in gut, airway, and skin microbiota are associated with impaired immune maturation and higher susceptibility to asthma and allergies. Aim The aim of this study is to review current knowledge on how the human microbiome influences the development, course, and severity of bronchial asthma, including its role in immune regulation, asthma phenotypes, the gut-lung axis, and potential microbiome-based therapies. Materials and Methods This review integrates current evidence using literature from PubMed, Google Scholar, and academic texts with keywords related to the microbiome, gut–lung axis, asthma, dysbiosis, and microbiome-targeted interventions. Experimental, cohort, and clinical studies were analysed. Results The microbiome plays a crucial role in asthma development, especially early in life. Microbial composition is shaped by delivery mode, breastfeeding, antibiotic exposure, and environmental diversity. Cesarean delivery and persistent dysbiosis increase asthma risk, while breastfeeding promotes protective profiles. Early gut dysbiosis - such as reduced SCFA-producing bacteria - affects immune maturation and contributes to distinct asthma phenotypes. Airway colonization by Proteobacteria (e.g., Haemophilus, Moraxella) is associated with severe disease, steroid resistance, and frequent exacerbations. Microbiome-targeted strategies, including probiotics, postbiotics, and fecal microbiota transplantation, show therapeutic potential. Conclusions The microbiome is a key regulator of immune development and a major contributor to asthma risk. Microbiome-based interventions are promising but require further well-designed clinical research.
- 29 November 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 47, 66794
Open AccessThe influence of the microbiome on the development and course of bronchial asthma – a comprehensive review
Background Asthma is a chronic airway disease increasingly linked to alterations in the human microbiome. Early-life disruptions in gut, airway, and skin microbiota are associated with impaired immune maturation and higher susceptibility to asthma and allergies. Aim The aim of this study is to review current knowledge on how the human microbiome influences the development, course, and severity of bronchial asthma, including its role in immune regulation, asthma phenotypes, the gut-lung axis, and potential microbiome-based therapies. Materials and Methods This review integrates current evidence using literature from PubMed, Google Scholar, and academic texts with keywords related to the microbiome, gut–lung axis, asthma, dysbiosis, and microbiome-targeted interventions. Experimental, cohort, and clinical studies were analysed. Results The microbiome plays a crucial role in asthma development, especially early in life. Microbial composition is shaped by delivery mode, breastfeeding, antibiotic exposure, and environmental diversity. Cesarean delivery and persistent dysbiosis increase asthma risk, while breastfeeding promotes protective profiles. Early gut dysbiosis - such as reduced SCFA-producing bacteria - affects immune maturation and contributes to distinct asthma phenotypes. Airway colonization by Proteobacteria (e.g., Haemophilus, Moraxella) is associated with severe disease, steroid resistance, and frequent exacerbations. Microbiome-targeted strategies, including probiotics, postbiotics, and fecal microbiota transplantation, show therapeutic potential. Conclusions The microbiome is a key regulator of immune development and a major contributor to asthma risk. Microbiome-based interventions are promising but require further well-designed clinical research.
- Open Access
- 20 November 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 46
Smarter, Faster, Safer: How AI Is Rewiring Sports, Performance Science, and Athlete Health
Background. Artificial intelligence (AI) is rapidly permeating sports medicine and performance science, propelled by high-volume data from wearables, video, and clinical systems. Beyond traditional analytics, modern machine learning (ML) and deep learning (DL) can model complex, nonlinear relationships to support diagnosis, injury prevention, load management, and tactical decisions. Yet adoption remains uneven due to concerns about data quality, bias, interpretability, governance, and the appropriate balance between automation and expert judgment. Aim. To synthesize emerging evidence on AI applications across sports medicine and performance optimization, clarifying opportunities, constraints, and ethical considerations required for safe, effective, and equitable integration. Material and methods. Narrative review of AI modalities, core data ecosystems and representative use cases spanning MSK imaging, injury-risk modeling, movement analysis, recovery optimization, and tactical decision support. The review emphasizes multimodal data fusion, model oversight, and real-world implementation factors. Current state of knowledge. Evidence indicates AI can enhance diagnostic speed and accuracy in MSK imaging, improve early detection of overuse and acute injury risk via spatiotemporal and physiological signals. enable individualized load management and adaptive training through time-series modeling; and support coaching and education via NLP and LLM-powered tools. Key limitations include dataset heterogeneity, biased sampling and gaps between prototype performance and field deployment. Conclusions. AI can make training and care more precise, proactive, and accessible, but benefits hinge on high-quality data pipelines, transparent models, clinician/coach oversight, and ethical safeguards. Interdisciplinary collaboration is essential to realize performance gains while protecting athlete welfare and equity.
- 20 November 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 46
Open AccessSmarter, Faster, Safer: How AI Is Rewiring Sports, Performance Science, and Athlete Health
Background. Artificial intelligence (AI) is rapidly permeating sports medicine and performance science, propelled by high-volume data from wearables, video, and clinical systems. Beyond traditional analytics, modern machine learning (ML) and deep learning (DL) can model complex, nonlinear relationships to support diagnosis, injury prevention, load management, and tactical decisions. Yet adoption remains uneven due to concerns about data quality, bias, interpretability, governance, and the appropriate balance between automation and expert judgment. Aim. To synthesize emerging evidence on AI applications across sports medicine and performance optimization, clarifying opportunities, constraints, and ethical considerations required for safe, effective, and equitable integration. Material and methods. Narrative review of AI modalities, core data ecosystems and representative use cases spanning MSK imaging, injury-risk modeling, movement analysis, recovery optimization, and tactical decision support. The review emphasizes multimodal data fusion, model oversight, and real-world implementation factors. Current state of knowledge. Evidence indicates AI can enhance diagnostic speed and accuracy in MSK imaging, improve early detection of overuse and acute injury risk via spatiotemporal and physiological signals. enable individualized load management and adaptive training through time-series modeling; and support coaching and education via NLP and LLM-powered tools. Key limitations include dataset heterogeneity, biased sampling and gaps between prototype performance and field deployment. Conclusions. AI can make training and care more precise, proactive, and accessible, but benefits hinge on high-quality data pipelines, transparent models, clinician/coach oversight, and ethical safeguards. Interdisciplinary collaboration is essential to realize performance gains while protecting athlete welfare and equity.